Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37


The embodiment of language in tremor-dominant Parkinson's disease patients.

Nisticò R, Cerasa A, Olivadese G, Dalla Volta R, Crasà M, Vasta R, Gramigna V, Vescio B, Barbagallo G, Chiriaco C, Quattrone A, Salsone M, Novellino F, Arabia G, Nicoletti G, Morelli M, Quattrone A.

Brain Cogn. 2019 Oct;135:103586. doi: 10.1016/j.bandc.2019.103586. Epub 2019 Jul 18.


Functional activity changes in memory and emotional systems of healthy subjects with déjà vu.

Nigro S, Cavalli SM, Cerasa A, Riccelli R, Fortunato F, Bianco MG, Martino I, Chiriaco C, Vaccaro MG, Quattrone A, Gambardella A, Labate A.

Epilepsy Behav. 2019 Aug;97:8-14. doi: 10.1016/j.yebeh.2019.05.018. Epub 2019 Jun 7.


REM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance?

Salsone M, Arabia G, Manfredini L, Quattrone A, Chiriaco C, Vescio B, Sturniolo M, Morelli M, Nistico' R, Novellino F, Gambardella A, Quattrone A.

Front Neurol. 2019 Apr 24;10:315. doi: 10.3389/fneur.2019.00315. eCollection 2019.


Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours.

Martin V, Chiriaco C, Modica C, Acquadro A, Cortese M, Galimi F, Perera T, Gammaitoni L, Aglietta M, Comoglio PM, Vigna E, Sangiolo D.

Br J Cancer. 2019 Mar;120(5):527-536. doi: 10.1038/s41416-018-0315-3. Epub 2019 Feb 6.


In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.

Barbagallo G, Morelli M, Quattrone A, Chiriaco C, Vaccaro MG, Gullà D, Rocca F, Caracciolo M, Novellino F, Sarica A, Arabia G, Sabatini U, Quattrone A.

Parkinsonism Relat Disord. 2019 May;62:185-191. doi: 10.1016/j.parkreldis.2018.12.008. Epub 2018 Dec 11.


A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.


Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Oct;265(10):2243-2250. doi: 10.1007/s00415-018-8980-y. Epub 2018 Jul 26.


Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.

Saccà V, Sarica A, Novellino F, Barone S, Tallarico T, Filippelli E, Granata A, Chiriaco C, Bruno Bossio R, Valentino P, Quattrone A.

Brain Imaging Behav. 2019 Aug;13(4):1103-1114. doi: 10.1007/s11682-018-9926-9.


Relationship between Hippocampal Subfields and Category Cued Recall in AD and PDD: A Multimodal MRI Study.

Novellino F, Vasta R, Sarica A, Chiriaco C, Salsone M, Morelli M, Arabia G, Saccà V, Nicoletti G, Quattrone A.

Neuroscience. 2018 Feb 10;371:506-517. doi: 10.1016/j.neuroscience.2017.12.028. Epub 2017 Dec 29.


Color vision as a biological marker able to differentiate two phenotypically similar neurological diseases.

Piro A, Tagarelli A, Nicoletti G, Chiriaco C, Novellino F, Quattrone A.

Neurol Sci. 2018 May;39(5):951-952. doi: 10.1007/s10072-017-3219-8. Epub 2017 Dec 14. No abstract available.


Neuropsychological heterogeneity in patients with primary familial brain calcification due to a novel mutation in SLC20A2.

Chiriaco C, Novellino F, Salsone M, Gagliardi M, Morelli M, Quattrone A.

Neurol Sci. 2018 Feb;39(2):379-380. doi: 10.1007/s10072-017-3125-0. Epub 2017 Sep 21. No abstract available.


Processing graspable object images and their nouns is impaired in Parkinson's disease patients.

Buccino G, Dalla Volta R, Arabia G, Morelli M, Chiriaco C, Lupo A, Silipo F, Quattrone A.

Cortex. 2018 Mar;100:32-39. doi: 10.1016/j.cortex.2017.03.009. Epub 2017 Mar 27.


MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.

Quattrone A, Morelli M, Williams DR, Vescio B, Arabia G, Nigro S, Nicoletti G, Salsone M, Novellino F, Nisticò R, Pucci F, Chiriaco C, Pugliese P, Bosco D, Caracciolo M.

Neurology. 2016 Sep 20;87(12):1266-73. doi: 10.1212/WNL.0000000000003125. Epub 2016 Aug 24.


Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody.

Cignetto S, Modica C, Chiriaco C, Fontani L, Milla P, Michieli P, Comoglio PM, Vigna E.

Mol Oncol. 2016 Jun;10(6):938-48. doi: 10.1016/j.molonc.2016.03.004. Epub 2016 Mar 28.


Cerebellar involvement in essential tremor with and without resting tremor: A Diffusion Tensor Imaging study.

Novellino F, Nicoletti G, Cherubini A, Caligiuri ME, Nisticò R, Salsone M, Morelli M, Arabia G, Cavalli SM, Vaccaro MG, Chiriaco C, Quattrone A.

Parkinsonism Relat Disord. 2016 Jun;27:61-6. doi: 10.1016/j.parkreldis.2016.03.022. Epub 2016 Mar 30.


Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients.

Riccelli R, Passamonti L, Cerasa A, Nigro S, Cavalli SM, Chiriaco C, Valentino P, Nisticò R, Quattrone A.

Mult Scler. 2016 Jul;22(8):1094-105. doi: 10.1177/1352458515606987. Epub 2015 Oct 9.


Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.

Vigna E, Chiriaco C, Cignetto S, Fontani L, Basilico C, Petronzelli F, Comoglio PM.

Mol Oncol. 2015 Nov;9(9):1760-72. doi: 10.1016/j.molonc.2015.05.007. Epub 2015 Jun 5.


The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.

Caligiuri ME, Barone S, Cherubini A, Augimeri A, Chiriaco C, Trotta M, Granata A, Filippelli E, Perrotta P, Valentino P, Quattrone A.

Neuroimage Clin. 2014 Nov 18;7:28-33. doi: 10.1016/j.nicl.2014.11.008. eCollection 2015.


Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling.

Cerasa A, Salsone M, Nigro S, Chiriaco C, Donzuso G, Bosco D, Vasta R, Quattrone A.

Parkinsonism Relat Disord. 2014 Nov;20(11):1209-14. doi: 10.1016/j.parkreldis.2014.09.001. Epub 2014 Sep 9.


Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.

Morelli M, Arabia G, Messina D, Vescio B, Salsone M, Chiriaco C, Perrotta P, Rocca F, Cascini GL, Barbagallo G, Nigro S, Quattrone A.

Mov Disord. 2014 Apr;29(4):488-95. doi: 10.1002/mds.25821. Epub 2014 Feb 26.


Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study.

Cerasa A, Gioia MC, Salsone M, Donzuso G, Chiriaco C, Realmuto S, Nicoletti A, Bellavia G, Banco A, D'amelio M, Zappia M, Quattrone A.

Neurol Sci. 2014 Aug;35(8):1173-80. doi: 10.1007/s10072-014-1666-z. Epub 2014 Feb 20.


Diffusion tensor MRI changes in gray structures of the frontal-subcortical circuits in amyotrophic lateral sclerosis.

Barbagallo G, Nicoletti G, Cherubini A, Trotta M, Tallarico T, Chiriaco C, Nisticò R, Salvino D, Bono F, Valentino P, Quattrone A.

Neurol Sci. 2014 Jun;35(6):911-8. doi: 10.1007/s10072-013-1626-z. Epub 2014 Jan 17.


Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor.

Vigna E, Pacchiana G, Chiriaco C, Cignetto S, Fontani L, Michieli P, Comoglio PM.

J Mol Med (Berl). 2014 Jan;92(1):65-76. doi: 10.1007/s00109-013-1079-0. Epub 2013 Sep 7.


A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity.

Olwill SA, Joffroy C, Gille H, Vigna E, Matschiner G, Allersdorfer A, Lunde BM, Jaworski J, Burrows JF, Chiriaco C, Christian HJ, Hülsmeyer M, Trentmann S, Jensen K, Hohlbaum AM, Audoly L.

Mol Cancer Ther. 2013 Nov;12(11):2459-71. doi: 10.1158/1535-7163.MCT-13-0318. Epub 2013 Sep 3.


Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease.

Passamonti L, Salsone M, Toschi N, Cerasa A, Giannelli M, Chiriaco C, Cascini GL, Fera F, Quattrone A.

Brain Behav. 2013 May;3(3):249-62. doi: 10.1002/brb3.115. Epub 2013 Mar 22.


Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET.

Basilico C, Pennacchietti S, Vigna E, Chiriaco C, Arena S, Bardelli A, Valdembri D, Serini G, Michieli P.

Clin Cancer Res. 2013 May 1;19(9):2381-92. doi: 10.1158/1078-0432.CCR-12-3459. Epub 2013 Mar 26.


MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.

Cerasa A, Valentino P, Chiriaco C, Pirritano D, Nisticò R, Gioia CM, Trotta M, Del Giudice F, Tallarico T, Rocca F, Augimeri A, Bilotti G, Quattrone A.

J Neurol. 2013 May;260(5):1358-66. doi: 10.1007/s00415-012-6805-y. Epub 2012 Dec 28.


Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study.

Novellino F, Cherubini A, Chiriaco C, Morelli M, Salsone M, Arabia G, Quattrone A.

Mov Disord. 2013 Feb;28(2):196-200. doi: 10.1002/mds.25263. Epub 2012 Dec 12.


Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates.

Cerasa A, Gioia MC, Valentino P, Nisticò R, Chiriaco C, Pirritano D, Tomaiuolo F, Mangone G, Trotta M, Talarico T, Bilotti G, Quattrone A.

Neurorehabil Neural Repair. 2013 May;27(4):284-95. doi: 10.1177/1545968312465194. Epub 2012 Nov 27.


Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.

Cerasa A, Passamonti L, Valentino P, Nisticò R, Pirritano D, Gioia MC, Chiriaco C, Mangone G, Perrotta P, Quattrone A.

Exp Neurol. 2012 Oct;237(2):418-26. doi: 10.1016/j.expneurol.2012.07.020. Epub 2012 Aug 7.


Altered cortical-cerebellar circuits during verbal working memory in essential tremor.

Passamonti L, Novellino F, Cerasa A, Chiriaco C, Rocca F, Matina MS, Fera F, Quattrone A.

Brain. 2011 Aug;134(Pt 8):2274-86. doi: 10.1093/brain/awr164. Epub 2011 Jul 11.


Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody.

Pacchiana G, Chiriaco C, Stella MC, Petronzelli F, De Santis R, Galluzzo M, Carminati P, Comoglio PM, Michieli P, Vigna E.

J Biol Chem. 2010 Nov 12;285(46):36149-57. doi: 10.1074/jbc.M110.134031. Epub 2010 Sep 10.


Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.

Valentino P, Cerasa A, Chiriaco C, Nisticò R, Pirritano D, Gioia M, Lanza P, Canino M, Del Giudice F, Gallo O, Condino F, Torchia G, Quattrone A.

Mult Scler. 2009 Jul;15(7):854-9. doi: 10.1177/1352458509104589.


Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.

Novellino F, Bagnato A, Salsone M, Cascini GL, Nicoletti G, Arabia G, Pugliese P, Morelli M, Paglionico S, Cipullo S, Manna I, De Marco EV, Condino F, Chiriaco C, Morgante L, Zappia M, Quattrone A.

Neurobiol Aging. 2010 Nov;31(11):1903-11. doi: 10.1016/j.neurobiolaging.2008.11.009. Epub 2009 Jan 9.


Neuropsychological disturbances in frontal lobe epilepsy due to mutated nicotinic receptors.

Picard F, Pegna AJ, Arntsberg V, Lucas N, Kaczmarek I, Todica O, Chiriaco C, Seeck M, Brodtkorb E.

Epilepsy Behav. 2009 Feb;14(2):354-9. doi: 10.1016/j.yebeh.2008.11.003. Epub 2008 Dec 6.


"Active" cancer immunotherapy by anti-Met antibody gene transfer.

Vigna E, Pacchiana G, Mazzone M, Chiriaco C, Fontani L, Basilico C, Pennacchietti S, Comoglio PM.

Cancer Res. 2008 Nov 15;68(22):9176-83. doi: 10.1158/0008-5472.CAN-08-1688.


[Surgical treatment of gastric cancer. New experimental reconstructive technic after total gastrectomy].

Catona A, Tinozzi S, Rovati L, Pagani L, Valesi MG, Parziale A, Chiriaco C.

Chir Ital. 1980 Aug;32(4):763-75. Italian.


Supplemental Content

Loading ...
Support Center